1. 2022
  2. Published

    Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer

    Kreis, K., Horenkamp-Sonntag, D., Schneider, U., Zeidler, J., Glaeske, G. & Weissbach, L., 28 Mar 2022, In: BJU international. 129, 4, p. 470-479 10 p.

    Research output: Contribution to journalArticleResearchpeer review